AIkido Pharma Statistics

Share Statistics

AIkido Pharma has 5.49M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	5.49M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	4.38M
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 83.79K, so 0% of the outstanding shares have been sold short.

Short Interest	83.79K
Short % of Shares Out	n/a
Short % of Float	1.64%
Short Ratio (days to cover)	1.75

Valuation Ratios

The PE ratio is -1.5 and the forward PE ratio is null. AIkido Pharma's PEG ratio is 0.

PE Ratio	-1.5
Forward PE	n/a
PS Ratio	1.21
Forward PS	n/a
PB Ratio	0.55
P/FCF Ratio	-1.46
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for AIkido Pharma.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.44, with a Debt / Equity ratio of 0.08.

Current Ratio	7.44
Quick Ratio	7.44
Debt / Equity	0.08
Debt / EBITDA	-0.26
Debt / FCF	-0.2
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$4.54M
Profits Per Employee	$-3.68M
Employee Count	4
Asset Turnover	0.39
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 0, so AIkido Pharma's price volatility has been lower than the market average.

Beta	0
52-Week Price Change	n/a
50-Day Moving Average	4.72
200-Day Moving Average	5.81
Relative Strength Index (RSI)	32.17
Average Volume (20 Days)	35,256

Income Statement

In the last 12 months, AIkido Pharma had revenue of 18.15M and earned -14.7M in profits. Earnings per share was -2.38.

Revenue	18.15M
Gross Profit	n/a
Operating Income	-11.53M
Net Income	-14.7M
EBITDA	-11.53M
EBIT	n/a
Earnings Per Share (EPS)	-2.38

Full Income Statement

Balance Sheet

The company has 4.08M in cash and 3.04M in debt, giving a net cash position of 1.04M.

Cash & Cash Equivalents	4.08M
Total Debt	3.04M
Net Cash	1.04M
Retained Earnings	-223.47M
Total Assets	109.34M
Working Capital	43.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.12M and capital expenditures 0, giving a free cash flow of -15.12M.

Operating Cash Flow	-15.12M
Capital Expenditures	n/a
Free Cash Flow	-15.12M
FCF Per Share	-2.44

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-63.52%
Pretax Margin	-81.03%
Profit Margin	-81.03%
EBITDA Margin	-63.52%
EBIT Margin	-63.52%
FCF Margin	-83.31%

Dividends & Yields

AIKI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for AIKI.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Jun 7, 2022. It was a backward split with a ratio of 1:17.

Last Split Date	Jun 7, 2022
Split Type	backward
Split Ratio	1:17

Scores

Altman Z-Score	-3.14
Piotroski F-Score	4

AIkido Pharma Inc. (AIKI)